AKAP1 and Parkinson disease: A reduction in AKAP1/PKA signaling contributes to early-stage degeneration in various neurodegenerative disorders, including AD and PD [96], suggesting a potential role of PKA/AKAP1 signaling in neurodegeneration and neuroprotection.